High-Value Research of 2014 Presented for Rheumatology

Share this content:
High-Value Research of 2014 Presented for Rheumatology
High-Value Research of 2014 Presented for Rheumatology

WEDNESDAY, May 6, 2015 (HealthDay News) -- Articles relating to arthritis treatment, vasculitides, and scleroderma are included in a special update summary published online April 30 in the Annals of Internal Medicine.

David B. Hellman, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and John B. Imboden, M.D., from the University of California in San Diego, searched the medical literature and summarized key rheumatology studies published in 2014 that were the highest quality and of most importance to internists.

The authors included articles that provide information about a new therapy for psoriatic arthritis (anti-interleukin-17 receptor A); the most effective strategy for initial treatment and sustaining remission in rheumatoid arthritis; the best ways to sustain remission in antineutrophil cytoplasmic antibody-associated vasculitis; the value of glucocorticoid epidural injections in treating lumbar spinal stenosis; and the long-term safety of hydroxychloroquine. Genetic studies performed in families with multiple affected members provided results about the cause of polyarteritis nodosa. Finally, in some patients, scleroderma was identified as a paraneoplastic disease in which cancer is the foreign antigen which triggers the disease.

"We searched the medical literature published in 2014 to identify rigorously performed studies that added important new information about the treatment of rheumatic diseases or provided paradigm-shifting insights into the cause of these diseases," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »